bromfenac Duract withdrawn
Selected indexed studies
- Role of microsomal metabolism in bromfenac-induced cytotoxicity. (Chem Biol Interact, 2024) [PMID:38331335]
- Bromfenac (Duract)-associated hepatic failure requiring liver transplantation. (Am J Gastroenterol, 1999) [PMID:10445569]
- Clinical pharmacokinetics and pharmacodynamics of bromfenac. (Clin Pharmacokinet, 1999) [PMID:10427465]
_Worker-drafted node — pending editorial review._
Connections
bromfenac Duract withdrawn is a side effect of
Sources
- Role of microsomal metabolism in bromfenac-induced cytotoxicity. (2024) pubmed
- Clinical pharmacokinetics and pharmacodynamics of bromfenac. (1999) pubmed
- Bromfenac (Duract)-associated hepatic failure requiring liver transplantation. (1999) pubmed
- Drug-induced liver disease. (1999) pubmed
- A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. (2006) pubmed
- Safety data and withdrawal of hepatotoxic drugs. (2021) pubmed
- Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? (2010) pubmed
- Metabolite Profiling and Reaction Phenotyping for the in Vitro Assessment of the Bioactivation of Bromfenac †. (2020) pubmed
- Acute liver failure. (2001) pubmed
- Role of Glucuronidation and P450 Oxidation in the Bioactivation of Bromfenac. (2018) pubmed